Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Events, Stroke, and Mortality in Patients with Type 2 Diabetes

被引：0
|
作者：
Kawada, Tomoyuki [1 ]
机构：
[1] Nippon Med Sch, Dept Hyg & Publ Hlth, 1 1 5 Sendagi Bunkyo Ku, Tokyo 1138602, Japan
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 2023年 / 37卷 / 04期
关键词：
OUTCOMES;
D O I：
10.1007/s10557-022-07374-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：619 / 620
页数：2
相关论文
共 50 条
  • [41] Beneficial effect of sodium-glucose cotransporter-2 inhibitors on mortality among patients with cancer and diabetes mellitus
    Hu, Wei-Syun
    Lin, Cheng-Li
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025, 398 (04) : 4355 - 4360
  • [42] Hypothetical intervention of sodium-glucose cotransporter-2 inhibitors on renal outcome in type 2 diabetes
    Takeuchi, Masato
    Kawakami, Koji
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 131 - 132
  • [43] Mortality Outcomes With Different Sodium-glucose Cotransporter-2 Inhibitors: Are They Dissimilar?
    Singh, Awadhesh Kumar
    ENDOCRINE PRACTICE, 2022, 28 (10) : 1107 - 1108
  • [44] Sodium-glucose cotransporter-2 inhibitors and genital and urinary tract infections in type 2 diabetes
    Arakaki, Richard F.
    POSTGRADUATE MEDICINE, 2016, 128 (04) : 409 - 417
  • [45] Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Weight in Type 2 Diabetes Mellitus and Therapeutic Regimen Recommendation
    Wang, Dong-Dong
    Mao, Yi-Zhen
    Yang, Yang
    Wang, Tian-Yun
    Zhu, Ping
    He, Su-Mei
    Chen, Xiao
    JOURNAL OF DIABETES RESEARCH, 2022, 2022
  • [46] Effects of Sodium-Glucose Cotransporter-2 Inhibitors on the Risk of Atrial Fibrillation in Older Adults with Type 2 Diabetes
    Li, Yujia
    Guo, Yi
    Kimmel, Stephen
    Bian, Jiang
    Schatz, Desmond
    Guo, Jingchuan
    DIABETES, 2023, 72
  • [47] Sodium-glucose cotransporter-2 inhibitors in diabetes and inflammatory skin diseases
    Shen, Chin-Hsuan
    Yang, Yi-Sun
    Lee, Irene Tai-Lin
    Chiang, Meng-Han
    Chen, Steven T.
    Ma, Kevin Sheng-Kai
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (03) : 467 - 468
  • [48] Should sodium-glucose cotransporter-2 inhibitors be first-line treatment for patients with type 2 diabetes?
    van Walraven, Carl
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (14) : E375 - E376
  • [49] Prevention of cardiovascular disease and renal failure in type 2 diabetes: sodium-glucose cotransporter-2 (SGLT2) inhibitors
    O'Sullivan, Jack W.
    BMJ EVIDENCE-BASED MEDICINE, 2020, 25 (02) : 79 - 80
  • [50] Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer
    Chiang, Cho-Han
    Chiang, Cho-Hung
    Chiang, Cho-Hsien
    Ma, Kevin Sheng-Kai
    Peng, Chun-Yu
    Hsia, Yuan Ping
    Horng, Chuan-Sheng
    Chen, Cheng-Ying
    Chang, Yu-Cheng
    See, Xin Ya
    Chen, Yuan-Jen
    Wang, Shih-Syuan
    Suero-Abreu, Giselle A.
    Peterson, L. R.
    Thavendiranathan, Paaladinesh
    Armand, Philippe
    Peng, Cheng-Ming
    Shiah, Her-Shyong
    Neilan, Tomas G.
    HEART, 2023, 109 (06) : 470 - 477
12345